Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tissue and blood-based miRNA biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer

Tissue and blood-based miRNA biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer

US Patent 9868992 · Granted Jan 16, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Detection method2024
Methods for diagnosing and treating gastric cancer using miRNA expression2023
Methods for diagnosing, prognosing, and treating colorectal cancer using biomark2023
Methods for diagnosing and treating esophageal cancer2023
Laser endoscope device2021
Methods and compositions involving transmembrane and coiled-coil domains 3 (TM-C2020
Identification of metastasis-specific miRNA and hypomethylation signatures in hu2019
Identification of metastasis-specific miRNA and hypomethylation signatures in hu2019
Identification of metastasis-specific miRNA and hypomethylation signatures in hu2019
MiR-320e and colorectal cancer2019
MiR-320e and colorectal cancer2019
Ulcerative colitis (UC)-associated colorectal neoplasia markers2019